Influenza infection and risk of acute myocardial infarction in England and Wales: a CALIBER self-controlled case series study

Charlotte Warren-Gash, Andrew C Hayward, Harry Hemingway, Spiros Denaxas, Sara L Thomas, Adam D Timmis, Heather Whitaker, Liam Smeeth, Charlotte Warren-Gash, Andrew C Hayward, Harry Hemingway, Spiros Denaxas, Sara L Thomas, Adam D Timmis, Heather Whitaker, Liam Smeeth

Abstract

Background: An association between infections and vascular events has been observed, but the specific effect of influenza and influenza-like illnesses on triggering acute myocardial infarction (AMI) is unclear.

Methods: Episodes of first AMI from 1 January 2003 through 31 July 2009 were identified using linked anonymized electronic medical records from the Myocardial Ischaemia National Audit Project and the General Practice Research Database. Self-controlled case series analysis was used to investigate AMI risks after consultation for acute respiratory infection. Infections were stratified by influenza virus circulation, diagnostic code, and vaccination status to assess whether influenza was more likely than other infections to trigger AMI.

Results: Of 22,024 patients with acute coronary syndrome, 11,208 met the criterion of having had their first AMI at the age of ≥ 40 years, and 3927 had also consulted for acute respiratory infection. AMI risks were significantly raised during days 1-3 after acute respiratory infection (incidence ratio, 4.19 [95% confidence interval, 3.18-5.53], with the effect tapering over time. The effect was greatest in those aged ≥ 80 years (P = .023). Infections occurring when influenza was circulating and those coded as influenza-like illness were associated with consistently higher incidence ratios for AMI (P = .012).

Conclusions: Influenza and other acute respiratory infections can act as a trigger for AMI. This effect may be stronger for influenza than for other infections.

Clinical trials registration: NCT01106196.

Figures

Figure 1.
Figure 1.
Selection of records on initial acute myocardial infarctions (AMIs) from the Myocardial Ischaemia National Audit Project (MINAP) database on acute coronary syndrome (ACS).

References

    1. Scarborough P, Bhatnagar P, Wickramsinghe K, Smolina K, Mitchell C, Rayner M. Coronary heart disease statistics. British Heart Foundation report. 2010 . Accessed 13 March 2012.
    1. Warren-Gash C, Smeeth L, Hayward AC. Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review. Lancet Infect Dis. 2009;9:601–10.
    1. Tillett HE, Smith JW, Gooch CD. Excess deaths attributable to influenza in England and Wales: age at death and certified cause. Int J Epidemiol. 1983;12:344–52.
    1. Warren-Gash C, Bhaskaran K, Hayward A, et al. Circulating influenza virus, climatic factors, and acute myocardial infarction: a time series study in England and Wales and Hong Kong. J Infect Dis. 2011;203:1710–8.
    1. Wong CM, Chan KP, Hedley AJ, Malik Peiris JS. Influenza-associated mortality in Hong Kong. Clin Infect Dis. 2004;39:1611–7.
    1. Smeeth L, Thomas SL, Hall AJ, Hubbard R, Farrington P, Vallance P. Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med. 2004;351:2611–8.
    1. Walley T, Mantgani A. The UK general practice research database. Lancet. 1997;350:1097–9.
    1. Herrett E, Smeeth L, Walker L, Weston C. The myocardial ischaemia national audit project (MINAP) Heart. 2010;96:1264–7.
    1. Thygesen K, Alpert JS, White HD. Universal definition of myocardial infarction. J Am Coll Cardiol. 2007;50:2173–95.
    1. CALIBER Web site. . Accessed 13 March 2012.
    1. General Practice Research Database Web site. . Accessed 13 March 2012.
    1. MINAP Steering Group. Myocardial Ischaemia National Audit Project (MINAP): How the NHS cares for patients with heart attack. Tenth Public Report. 2011 London: Padcreative.
    1. Dave S, Petersen I. Creating medical and drug code lists to identify cases in primary care databases. Pharmacoepidemiol Drug Saf. 2009;18:704–7.
    1. Whitaker HJ, Farrington CP, Spiessens B, Musonda P. Tutorial in biostatistics: the self-controlled case series method. Stat Med. 2006;25:1768–97.
    1. Boggon R, van Staa TP, Timmis A, et al. Clopidogrel discontinuation after acute coronary syndromes: frequency, predictors and associations with death and myocardial infarction—a hospital registry-primary care linked cohort (MINAP-GPRD) Eur Heart J. 2011;32:2376–86.
    1. Herrett E, Thomas SL, Schoonen WM, Smeeth L, Hall AJ. Validation and validity of diagnoses in the general practice research database: a systematic review. Br J Clin Pharmacol. 2010;69:4–14.
    1. Khan NF, Harrison SE, Rose PW. Validity of diagnostic coding within the general practice research database: a systematic review. Br J Gen Pract. 2010;60:e128–36.
    1. Hammad TA, McAdams MA, Feight A, Iyasu S, Dal Pan GJ. Determining the predictive value of Read/OXMIS codes to identify incident acute myocardial infarction in the general practice research database. Pharmacoepidemiol Drug Saf. 2008;17:1197–201.
    1. Farrington CP, Anaya-Izquierdo K, Whitaker HJ, Hocine MN, Douglas I, Smeeth L. Self controlled case series analysis with event-dependent observation periods. JASA. 2011;106:417–26.
    1. Smeeth L, Donnan PT, Cook DG. The use of primary care databases: case-control and case-only designs. Fam Pract. 2006;23:597–604.
    1. Whitaker HJ, Hocine MN, Farrington CP. The methodology of self-controlled case series studies. Stat Methods Med Res. 2009;18:7–26.
    1. Da Silva PR, Nguyen VT, Hayward AC. Logistic issues and potential prescribing costs associated with use of neuraminidase inhibitors for the treatment of influenza in primary care. J R Soc Med. 2003;96:66–9.
    1. Little P, Williamson I, Warner G, Gould C, Gantley M, Kinmonth AL. Open randomised trial of prescribing strategies in managing sore throat. BMJ. 1997;314:722–7.
    1. Meier CR, Napalkov PN, Wegmuller Y, Jefferson T, Jick H. Population-based study on incidence, risk factors, clinical complications and drug utilisation associated with influenza in the United Kingdom. Eur J Clin Microbiol Infect Dis. 2000;19:834–42.
    1. Stowe J, Andrews N, Wise L, Miller E. Investigation of the temporal association of Guillain-Barre syndrome with influenza vaccine and influenzalike illness using the United Kingdom General Practice Research Database. Am J Epidemiol. 2009;169:382–8.
    1. Fleming DM, Andrews NJ, Ellis JS, et al. Estimating influenza vaccine effectiveness using routinely collected laboratory data. J Epidemiol Community Health. 2010;64:1062–7.
    1. Clayton TC, Thompson M, Meade TW. Recent respiratory infection and risk of cardiovascular disease: case-control study through a general practice database. Eur Heart J. 2008;29:96–103.
    1. Meier CR, Jick SS, Derby LE, Vasilakis C, Jick H. Acute respiratory-tract infections and risk of first-time acute myocardial infarction. Lancet. 1998;351:1467–71.
    1. Guan XR, Li X, Xin XM, et al. Influenza virus infection and risk of acute myocardial infarction. Inflammation. 2008;31:266–72.
    1. Mattila KJ. Viral and bacterial infections in patients with acute myocardial infarction. J Intern Med. 1989;225:293–6.
    1. Nicholls AC, Thomas M. Coxsackie virus infection in acute myocardial infarction. Lancet. 1977;1:883–4.
    1. Ponka A, Jalanko H, Ponka T, Stenvik M. Viral and mycoplasmal antibodies in patients with myocardial infarction. Ann Clin Res. 1981;13:429–32.
    1. Ciszewski A, Bilinska ZT, Brydak LB, et al. Influenza vaccination in secondary prevention from coronary ischaemic events in coronary artery disease: FLUCAD study. Eur Heart J. 2008;29:1350–8.
    1. Gurfinkel EP, Leon de la FR, Mendiz O, Mautner B. Flu vaccination in acute coronary syndromes and planned percutaneous coronary interventions (FLUVACS) study. Eur Heart J. 2004;25:25–31.
    1. Phrommintikul A, Kuanprasert S, Wongcharoen W, Kanjanavanit R, Chaiwarith R, Sukonthasarn A. Influenza vaccination reduces cardiovascular events in patients with acute coronary syndrome. Eur Heart J. 2011;32:1730–5.
    1. Gwini SM, Coupland CA, Siriwardena AN. The effect of influenza vaccination on risk of acute myocardial infarction: self-controlled case-series study. Vaccine. 2011;29:1145–9.
    1. Hung IF, Leung AY, Chu DW, et al. Prevention of acute myocardial infarction and stroke among elderly persons by dual pneumococcal and influenza vaccination: a prospective cohort study. Clin Infect Dis. 2010;51:1007–16.
    1. Siriwardena AN, Gwini SM, Coupland CA. Influenza vaccination, pneumococcal vaccination and risk of acute myocardial infarction: matched case-control study. CMAJ. 2010;182:1617–23.
    1. Health Protection Agency Web site. Influenza vaccination uptake monitoring on behalf of the Department of Health. . Accessed 12 October 2011.

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner